Overview

Trifecta Research Study

Status:
WITHDRAWN
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The Special Operations Care-Fund (SOC-F) will sponsor the application of four treatments - hormone replacement, magnetic resonance brain stimulation, ibogaine, and 5-Meo-DMT - to Special Operations Forces veterans with a history of combat deployments, traumatic brain injury, and problems with mental health and cognitive functioning. An observational study will be conducted in parallel by the Johns Hopkins Center for Psychedelic and Consciousness Research to determine the effectiveness and safety of each treatment, primarily through measuring post-treatment changes in PTSD symptoms and cognitive functioning.
Phase:
PHASE2
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
Special Operators Care Fund
Treatments:
Hormone Replacement Therapy
Ibogaine
Methoxydimethyltryptamines
Transcranial Magnetic Stimulation